鲁抗医药：第三季度净利润同比减少27.04%

Core Viewpoint - LuKang Pharmaceutical reported a mixed performance in its third-quarter results, with revenue growth but a significant decline in net profit [1] Financial Performance - In the third quarter, the company achieved an operating income of 1.47 billion yuan, representing a year-on-year increase of 5.97% [1] - The net profit attributable to shareholders for the third quarter was 34.36 million yuan, showing a year-on-year decrease of 27.04% [1] - For the first three quarters, the company recorded an operating income of 4.62 billion yuan, which is a year-on-year decline of 0.91% [1] - The net profit attributable to shareholders for the first three quarters was 141 million yuan, reflecting a significant year-on-year decrease of 59.32% [1]